Additional file 2: Table S1. of Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

Reynolds, Rebecca; Denison, Fiona; Juszczak, Ed; Bell, Jennifer; Penneycard, Jessica; Strachan, Mark; Lindsay, Robert; Alexander, Claire; Love, Corinne; Whyte, Sonia; Mackenzie, Fiona; Stenson, Ben; Norman, Jane

doi:10.6084/m9.figshare.c.3887452_D2.v1

12884_2017_1505_MOESM2_ESM.docx (49.25 kB)

Additional file 2: Table S1. of Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

journal contribution

posted on 2017-09-22, 05:00 authored by Rebecca Reynolds, Fiona Denison, Ed Juszczak, Jennifer Bell, Jessica Penneycard, Mark Strachan, Robert Lindsay, Claire Alexander, Corinne Love, Sonia Whyte, Fiona Mackenzie, Ben Stenson, Jane Norman

Secondary outcomes â Glycaemic control. Table S2. Clinical outcomes â Mother Table S3. Secondary outcomes â Clinical outcomes (infant). (DOCX 52 kb)

Funding

Chief Scientist Office Scotland

History

Usage metrics

Keywords

Gestational diabetes Metformin Glibenclamide Feasibility Patient preference

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: Table S1. of Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial

Funding

Chief Scientist Office Scotland

History

Usage metrics

Categories

Keywords

Licence

Exports